iTeos Therapeutics, Inc.
ITOS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $142 | $251 | $285 | $849 |
| Short-Term Investments | $353 | $281 | $328 | $0 |
| Receivables | $4 | $7 | $2 | $12 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $11 | $12 | $13 | $14 |
| Total Curr. Assets | $510 | $551 | $628 | $875 |
| Property Plant & Equip (Net) | $10 | $11 | $7 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $160 | $101 | $118 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $6 | $2 | $2 |
| Total NC Assets | $177 | $117 | $127 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $687 | $668 | $755 | $885 |
| Liabilities | – | – | – | – |
| Payables | $9 | $11 | $8 | $5 |
| Short-Term Debt | $1 | $1 | $2 | $2 |
| Tax Payable | $2 | $6 | $1 | $8 |
| Deferred Revenue | $1 | $2 | $14 | $281 |
| Other Curr. Liab. | $27 | $19 | $17 | $9 |
| Total Curr. Liab. | $40 | $40 | $42 | $304 |
| LT Debt | $4 | $5 | $4 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $53 | $48 | $46 | $23 |
| Total NC Liab. | $56 | $52 | $50 | $28 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $6 | $5 | $5 |
| Total Liabilities | $97 | $92 | $92 | $332 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$10 | $125 | $237 | $141 |
| AOCI | -$16 | -$13 | -$10 | -$1 |
| Other Equity | $616 | $464 | $436 | $413 |
| Total Equity | $590 | $575 | $663 | $553 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $687 | $668 | $755 | $885 |
| Net Debt | -$137 | -$245 | -$279 | -$842 |